SCHEMBL23808352

SCHEMBL23808352

Nc1ccn([C@H]2CCC(COP)O2)c(=O)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.49
PDE3A Q14432 3/20 0.49
CACNA1F O60840 2/20 0.49
ALB P02768 2/20 0.49
MAPT P10636 2/20 0.49
CACNA1D Q01668 2/20 0.49
CACNA1S Q13698 2/20 0.49
CACNA1C Q13936 2/20 0.49
POLG P54098 2/20 0.46
POLB P06746 1/20 0.44
ABL1 P00519 1/20 0.43
RIN1 Q13671 1/20 0.43
THRB P10828 1/20 0.43
MTOR P42345 1/20 0.43
MDM2 Q00987 1/20 0.43
NCOA1 Q15788 1/20 0.43
NCOA3 Q9Y6Q9 1/20 0.43
PDE4D Q08499 1/20 0.40
SLC29A1 Q99808 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23425434 1.00 LMNA (0.49) LMNAPDE3ACACNA1FALBMAPT
SCHEMBL27267581 0.88 LMNA (0.49) LMNAPDE3ACACNA1FALBMAPT
SCHEMBL15788423 0.88 LMNA (0.49) LMNAPDE3ACACNA1FALBMAPT
SCHEMBL15259219 0.88 LMNA (0.49) LMNAPDE3ACACNA1FALBMAPT
SCHEMBL18837710 0.88 LMNA (0.52) LMNAPDE3ACACNA1FALBMAPT
SCHEMBL24872399 0.88 LMNA (0.49) LMNAPDE3ACACNA1FALBMAPT
SCHEMBL12149545 0.88 LMNA (0.49) LMNAPDE3ACACNA1FALBMAPT
SCHEMBL20056930 0.86 LMNA (0.52) LMNAPDE3ACACNA1FALBMAPT
SCHEMBL21895836 0.85 POLG (0.49) LMNAPDE3ACACNA1FALBMAPT
SCHEMBL24229283 0.84 LMNA (0.46) LMNAPDE3ACACNA1FALBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2981542-B1 2',4'-FLUORO NUCLEOSIDES FOR THE TREATMENT OF HCV IDENIX PHARMACEUTICALS LLC (US) 2021-09-15 EP disclosed